240 related articles for article (PubMed ID: 31226324)
1. Voluntary exercise delays progressive deterioration of markers of metabolism and behavior in a mouse model of Parkinson's disease.
Lai JH; Chen KY; Wu JC; Olson L; Brené S; Huang CZ; Chen YH; Kang SJ; Ma KH; Hoffer BJ; Hsieh TH; Chiang YH
Brain Res; 2019 Oct; 1720():146301. PubMed ID: 31226324
[TBL] [Abstract][Full Text] [Related]
2. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
Sconce MD; Churchill MJ; Greene RE; Meshul CK
Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
[TBL] [Abstract][Full Text] [Related]
3. Exercise in an animal model of Parkinson's disease: Motor recovery but not restoration of the nigrostriatal pathway.
Churchill MJ; Pflibsen L; Sconce MD; Moore C; Kim K; Meshul CK
Neuroscience; 2017 Sep; 359():224-247. PubMed ID: 28754312
[TBL] [Abstract][Full Text] [Related]
4. Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.
Langley MR; Ghaisas S; Ay M; Luo J; Palanisamy BN; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2018 Jan; 64():240-255. PubMed ID: 28595911
[TBL] [Abstract][Full Text] [Related]
5. Voluntary Physical Exercise Improves Subsequent Motor and Cognitive Impairments in a Rat Model of Parkinson's Disease.
Hsueh SC; Chen KY; Lai JH; Wu CC; Yu YW; Luo Y; Hsieh TH; Chiang YH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419747
[TBL] [Abstract][Full Text] [Related]
6. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Voluntary Physical Exercise Exerts Neuroprotective Effects and Motor Disturbance Alleviation in a Rat Model of Parkinson's Disease.
Tsai WL; Chen HY; Huang YZ; Chen YH; Kuo CW; Chen KY; Hsieh TH
Behav Neurol; 2019; 2019():4829572. PubMed ID: 31885725
[TBL] [Abstract][Full Text] [Related]
9. Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease.
Good CH; Hoffman AF; Hoffer BJ; Chefer VI; Shippenberg TS; Bäckman CM; Larsson NG; Olson L; Gellhaar S; Galter D; Lupica CR
FASEB J; 2011 Apr; 25(4):1333-44. PubMed ID: 21233488
[TBL] [Abstract][Full Text] [Related]
10. Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson's disease.
Fifel K; Cooper HM
Neurobiol Dis; 2014 Nov; 71():359-69. PubMed ID: 25171792
[TBL] [Abstract][Full Text] [Related]
11. Treadmill exercise alleviates motor deficits and improves mitochondrial import machinery in an MPTP-induced mouse model of Parkinson's disease.
Koo JH; Cho JY; Lee UB
Exp Gerontol; 2017 Mar; 89():20-29. PubMed ID: 28062370
[TBL] [Abstract][Full Text] [Related]
12. Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson's Disease.
Klemann CJHM; Xicoy H; Poelmans G; Bloem BR; Martens GJM; Visser JE
Mol Neurobiol; 2018 Jul; 55(7):5639-5657. PubMed ID: 29019056
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
[TBL] [Abstract][Full Text] [Related]
15. Phenothiazine normalizes the NADH/NAD
Tapias V; McCoy JL; Greenamyre JT
Redox Biol; 2019 Jun; 24():101164. PubMed ID: 30925294
[TBL] [Abstract][Full Text] [Related]
16. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
17. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammation.
Pinto M; Nissanka N; Peralta S; Brambilla R; Diaz F; Moraes CT
Mol Neurodegener; 2016 Apr; 11():25. PubMed ID: 27038906
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.
Qi X; Davis B; Chiang YH; Filichia E; Barnett A; Greig NH; Hoffer B; Luo Y
J Neurochem; 2016 Sep; 138(5):746-57. PubMed ID: 27317935
[TBL] [Abstract][Full Text] [Related]
20. Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson's disease.
Pickrell AM; Pinto M; Hida A; Moraes CT
J Neurosci; 2011 Nov; 31(48):17649-58. PubMed ID: 22131425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
